SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, provided today a ...

SWK Holdings’ baby bond, trading slightly above par, offers an attractive return for income investors despite a potential short-duration call opportunity. The company’s year-to-date revenue ...

SWK Holdings Corporation is a life science focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. SWK provides non-dilutive financing to fuel ...

DALLAS, TX / ACCESSWIRE / January 6, 2025 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized ...

Originations: In November, SWK advanced $5.0M to existing borrower Journey Medical to help fund the company’s launch of Emrosi. In November, as part of a broader amendment SWK advanced $0.6M to ...

SWK continues to hold Moleculight preferred equity, which is carried at no value on SWK's balance sheet. About SWK Holdings Corporation SWK Holdings Corporation is a life science focused specialty ...